| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
What’s next for GLP-1s? - Scientists eye new treatment targets for popular weight-loss drugs, from heart failure to addiction
What’s next for GLP-1s? - Scientists eye new treatment targets for popular weight-loss drugs, from heart failure to addiction
Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other chronic diseases — many with few treatment options — such as heart failure, chronic liver disease, obstructive sleep apnea, and even substance use disorders. (Harvard Gazette, USA, 18.02.2026)
https://news.harvard.edu/gazette/story/2026/02/whats-next-for-glp-1s